It also supports healthy weight loss
162,163 Retatrutide (LY-3437943), a novel triple agonist developed by Eli Lilly that targets GLP-1R, GIPR and GCGR, has shown potential in preliminary clinical data for providing excellent blood sugar control and significant weight reduction
Features How to use: Major Ingredients Water, Glycerin, Betaine, Cyclopentasiloxane, Glyceryl Stearate, Peg-100 Stearate, Sodium Polyacrylate, Hydroxyethyl Acrylate/Sodium Acryloyldimethyltaurate Copolymer, Parfume, Phenoxyethanol, C13-14 Isoparaffin, Proline, Cyclohexasiloxane, C11-13 Isoparaffin, Xanthan Gum, Tocopherolacetate, Trideceth-6, Aluminum Chlorohydrate, Arbutin, Glutathione, Hamamelis Virginiana(Witch Hazel) Flower Water, Niacinamide, Propylene Glycol Ingredients subject to change at manufacturer's discretion
Additionally, domestic suppliers face Canadian consumer protection regulations, providing recourse if products fail to meet quality standards